• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子和趋化因子在脂肪性肝炎发展中的作用。

The role of cytokines and chemokines in the development of steatohepatitis.

作者信息

Lalor Patricia F, Faint Jeff, Aarbodem York, Hubscher Stefan G, Adams David H

机构信息

Liver Research Group, MRC Centre for Immune Regulation, Institute of Biomedical Research, University of Birmingham Medical School, Birmingham, United Kingdom.

出版信息

Semin Liver Dis. 2007 May;27(2):173-93. doi: 10.1055/s-2007-979470.

DOI:10.1055/s-2007-979470
PMID:17520517
Abstract

Nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) share similar morphological characteristics despite the obvious etiological differences between the two conditions. In both conditions the first manifestation of injury is the accumulation of fat within hepatocytes (steatosis), and in a proportion of patients this is followed by the development of necroinflammatory activity that leads to cirrhosis. Steatosis alone is considered to be relatively innocuous and is usually reversible, and it is the development of liver cell ballooning and inflammation (steatohepatitis) that determines whether a patient progresses to irreversible liver damage and fibrosis. This has led to the two-hit theory in which the first hit is accumulation of fat in the liver and the second hit involves an inflammatory insult or challenge to the liver, for example, through oxidative stress or in response to pathogenic stimuli such as endotoxin. Although the nature of the hits remains poorly understood, it is clear that the critical event in progression is the development of inflammation, and the fact that it is impossible to distinguish alcoholic from nonalcoholic steatohepatitis on histological grounds suggests that common pathogenic mechanisms are involved. We focus on the role of cytokines and particularly chemokines in instigating and driving the inflammatory infiltrate in steatohepatitis. A better understanding of this process might allow therapeutic intervention to switch off the inflammatory response before irreversible damage occurs in both ALD and NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)和酒精性肝病(ALD)尽管病因明显不同,但具有相似的形态学特征。在这两种疾病中,损伤的最初表现都是肝细胞内脂肪堆积(脂肪变性),并且在一部分患者中,随后会发展为坏死性炎症活动,进而导致肝硬化。单纯的脂肪变性被认为相对无害且通常是可逆的,而肝细胞气球样变和炎症(脂肪性肝炎)的发展才决定患者是否会进展为不可逆的肝损伤和纤维化。这导致了“二次打击”学说,其中第一次打击是肝脏中脂肪的堆积,第二次打击涉及对肝脏的炎症性损伤或挑战,例如通过氧化应激或对内毒素等致病刺激的反应。尽管对这些打击的本质仍了解甚少,但很明显疾病进展中的关键事件是炎症的发展,而且基于组织学无法区分酒精性和非酒精性脂肪性肝炎这一事实表明,其中涉及共同的致病机制。我们重点关注细胞因子尤其是趋化因子在引发和推动脂肪性肝炎炎症浸润中的作用。更好地理解这一过程可能会使治疗干预能够在ALD和NAFLD发生不可逆损伤之前抑制炎症反应。

相似文献

1
The role of cytokines and chemokines in the development of steatohepatitis.细胞因子和趋化因子在脂肪性肝炎发展中的作用。
Semin Liver Dis. 2007 May;27(2):173-93. doi: 10.1055/s-2007-979470.
2
Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.酒精性和非酒精性脂肪性肝炎的进展:固有免疫系统和氧化应激的共同代谢方面。
Drug Metab Pharmacokinet. 2011;26(1):30-46. doi: 10.2133/dmpk.dmpk-10-rv-087. Epub 2010 Dec 7.
3
Role of cytokines and chemokines in non-alcoholic fatty liver disease.细胞因子和趋化因子在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2012 Feb 28;18(8):727-35. doi: 10.3748/wjg.v18.i8.727.
4
[Non-alcoholic steatohepatitis : pathology and pathogenesis].[非酒精性脂肪性肝炎:病理与发病机制]
Nihon Rinsho. 2006 Jun;64(6):1107-13.
5
Inflammatory mediators of hepatic steatosis.肝脂肪变性的炎症介质。
Mediators Inflamm. 2010;2010:837419. doi: 10.1155/2010/837419. Epub 2010 Mar 16.
6
The epidemiology, pathogenesis and histopathology of fatty liver disease.脂肪性肝病的流行病学、发病机制和组织病理学。
Histopathology. 2012 Aug;61(2):141-52. doi: 10.1111/j.1365-2559.2011.04145.x. Epub 2012 Feb 28.
7
Combination of CCl with alcoholic and metabolic injuries mimics human liver fibrosis.CCl 与酒精和代谢损伤的联合作用模拟了人类肝纤维化。
Am J Physiol Gastrointest Liver Physiol. 2019 Aug 1;317(2):G182-G194. doi: 10.1152/ajpgi.00361.2018. Epub 2019 Jun 12.
8
[Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].[酒精性和非酒精性脂肪性肝炎:同一种疾病!I. 诊断与机制]
Rev Med Suisse. 2005 Sep 7;1(31):2026-8, 2030-1.
9
Apoptosis in alcoholic and nonalcoholic steatohepatitis.酒精性和非酒精性脂肪性肝炎中的细胞凋亡
Front Biosci. 2005 Sep 1;10:3093-9. doi: 10.2741/1765.
10
Activin A in nonalcoholic fatty liver disease.活化素 A 与非酒精性脂肪性肝病。
Vitam Horm. 2011;85:323-42. doi: 10.1016/B978-0-12-385961-7.00015-9.

引用本文的文献

1
Palmitate-induced downregulation of lipocalin prostaglandin D synthase accompanies hepatic lipid accumulation in HepG2 cells.棕榈酸酯诱导的脂质运载蛋白型前列腺素D合成酶下调与HepG2细胞中的肝脏脂质积累相伴。
Mol Cell Endocrinol. 2025 Jul 19;608:112615. doi: 10.1016/j.mce.2025.112615.
2
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors.酒精在脂肪性肝病中的作用:对伴有心脏代谢危险因素患者的影响。
Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08912-4.
3
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.
胆汁酸激活受体:整合非酒精性脂肪性肝病中的免疫与代谢调节
Liver Res. 2021 Sep 2;5(3):119-141. doi: 10.1016/j.livres.2021.08.003. eCollection 2021 Sep.
4
Associations between systemic inflammation indicators and nonalcoholic fatty liver disease: evidence from a prospective study.系统炎症指标与非酒精性脂肪性肝病的相关性:来自前瞻性研究的证据。
Front Immunol. 2024 Jun 24;15:1389967. doi: 10.3389/fimmu.2024.1389967. eCollection 2024.
5
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments.非酒精性脂肪性肝病:免疫机制与现行治疗方法。
World J Gastroenterol. 2023 Aug 28;29(32):4831-4850. doi: 10.3748/wjg.v29.i32.4831.
6
A high-trans fat, high-carbohydrate, high-cholesterol, high-cholate diet-induced nonalcoholic steatohepatitis mouse model and its hepatic immune response.一种高反式脂肪、高碳水化合物、高胆固醇、高胆酸盐饮食诱导的非酒精性脂肪性肝炎小鼠模型及其肝脏免疫反应。
Nutr Metab (Lond). 2023 May 27;20(1):28. doi: 10.1186/s12986-023-00749-w.
7
TGFβ priming enhances CXCR3-mediated mesenchymal stromal cell engraftment to the liver and enhances anti-inflammatory efficacy.TGFβ 预刺激增强了 CXCR3 介导的间充质基质细胞向肝脏的定植,并增强了抗炎疗效。
J Cell Mol Med. 2023 Mar;27(6):864-878. doi: 10.1111/jcmm.17698. Epub 2023 Feb 23.
8
Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition.清肝活血方通过抑制CXCL16预防实验性酒精性肝纤维化
Evid Based Complement Alternat Med. 2023 Jan 3;2023:5642713. doi: 10.1155/2023/5642713. eCollection 2023.
9
The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles.免疫系统在 NAFLD 发病机制中的作用及间充质干细胞衍生的细胞外囊泡的潜在治疗作用。
Stem Cell Res Ther. 2022 Jun 7;13(1):242. doi: 10.1186/s13287-022-02929-6.
10
The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis.炎症应激在脂质稳态失调和肝脂肪变性中的分子致病作用。
Genes Dis. 2014 Jul 27;1(1):106-112. doi: 10.1016/j.gendis.2014.07.007. eCollection 2014 Sep.